Skip to main content
. Author manuscript; available in PMC: 2009 Sep 25.
Published in final edited form as: Gynecol Oncol. 2007 Sep 5;107(2):177–185. doi: 10.1016/j.ygyno.2007.07.070

Table 2.

Patients Experiencing Acute Adverse Events

WAI Regimen
(n = 98)
CIM Regimen
(n = 99)
Grade Grade
Adverse Event 0 1 2 3 4 0 1 2 3 4
Anemia 88 5 4 1 0 41 12 35 10 1
Gastrointestinal 33 33 21 8 3 37 33 19 8 2
Genitourinary 82 13 3 0 0 77 12 10 0 0
Renal 98 0 0 0 0 97 1 1 0 0
Hepatic 94 2 0 1 1 94 4 1 0 0
Fever 97 1 0 0 0 87 3 9 0 0
Infection 97 0 0 1 0 98 0 0 0 1*
Fatigue 92 5 0 1 0 77 13 6 2 1
Alopecia 98 0 0 0 0 54 12 33 0 0
Peripheral Neuropathy 97 1 0 0 0 87 6 4 2 0
Central Neuropathy 96 2 0 0 0 79 9 4 7 0
Allergy 98 0 0 0 0 95 2 2 0 0
Cutaneous 89 4 5 0 0 96 3 0 0 0
Cardiovascular 97 0 0 0 1 92 2 1 2 2
Pulmonary 97 0 1 0 0 93 3 3 0 0
Pain 94 2 2 0 0 86 9 3 1 0
Metabolic 97 1 0 0 0 90 2 2 3 2

Abbreviations: WAI, whole abdominal irradiation; CIM, cisplatin, ifosfamide with mesna chemotherapy.

Adverse events summarized for those who initiated study treatment.

*

One patient died of a systemic infection complicated by neutropenia which was attributed to CIM treatment.